GENERIC DRUG ENTRY

Pharmaceutical drug products havebecome increasingly important to providingconsumers with a myriad of treatments andcures that increase life expectancy andenhance lives. It is critical to maintainappropriate incentives for the developmentof new drug products, because the necessaryresearch and development is risky andcostly. Innovation in the pharmaceuticalindustry, spurred in part by competitivemarket forces, continues to bring enormousbenefits to Americans.


http://www.ftc.gov/os/2002/07/genericdrugstudy.pdf

INDIAN PHARMACEUTICAL INDUSTRY

INTRODUCTIONThe Indian Pharmaceuticals sector has come a long way, being almost non-existing during1970, to a prominent provider of health care products, meeting almost 95% of country’spharmaceutical needs. The domestic pharmaceutical output has increased from Rs.4 billion in1970-71 to Rs.290 billion in 2003 at a compound growth rate (CAGR) of 13.7% per annum. Inthe financial year of 2003 the domestic pharma market was valued at approximately $ 6 billion.The global output of the Indian industry ranks 4th in terms of volume and 13th in terms of value.Indian pharmaceuticals industry had over 20,000 units. Around 260 constitutes organizedsector, while others existing in the small-scale sector.


http://www.intec-online.net/uploads/tx_intec/Pharmaindustrie_in_Indien_01.pdf